BioNTech SE (BNTX) · INSIDERData sourcesSEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago
Public companyBioNTech SE
BNTXCIK 0001776985
Price$87.51
1 year-15.4%
Disclosed transactions37
Buys / sells0 / 27
Max Insider Score24
Connections with evidence7
BNTX · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 15 |  Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $2.49M 27.0K sh | Oct 8, 2026 |
| Oct 9, 2026 traded Oct 8, 2026 |
| 19 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.45M 36.2K sh | Oct 9, 2026 | Oct 9, 2026 traded Oct 9, 2026 | +0d | SEC Form 4 | |
| 15 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $2.30M 24.0K sh | Oct 7, 2026 | Oct 7, 2026 traded Oct 7, 2026 | +0d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $2.03M 21.0K sh | Oct 6, 2026 | Oct 6, 2026 traded Oct 6, 2026 | +0d | SEC Form 4 | |
| 15 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $7.00M 72.0K sh | Oct 5, 2026 | Oct 6, 2026 traded Oct 5, 2026 | +1d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $1.64M 17.0K sh | Oct 2, 2026 | Oct 2, 2026 traded Oct 2, 2026 | +0d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $1.66M 17.0K sh | Oct 1, 2026 | Oct 2, 2026 traded Oct 1, 2026 | +1d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.34M 34.0K sh | Sep 29, 2026 | Sep 30, 2026 traded Sep 29, 2026 | +1d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.14M 32.0K sh | Sep 30, 2026 | Sep 30, 2026 traded Sep 30, 2026 | +0d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.35M 34.0K sh | Sep 28, 2026 | Sep 28, 2026 traded Sep 28, 2026 | +0d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $2.66M 27.0K sh | Sep 25, 2026 | Sep 28, 2026 traded Sep 25, 2026 | +3d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.86M 39.0K sh | Sep 24, 2026 | Sep 24, 2026 traded Sep 24, 2026 | +0d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $2.98M 30.0K sh | Sep 23, 2026 | Sep 24, 2026 traded Sep 23, 2026 | +1d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.23M 33.0K sh | Sep 21, 2026 | Sep 22, 2026 traded Sep 21, 2026 | +1d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $4.63M 46.0K sh | Sep 22, 2026 | Sep 22, 2026 traded Sep 22, 2026 | +0d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $2.89M 30.0K sh | Sep 18, 2026 | Sep 18, 2026 traded Sep 18, 2026 | +0d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.35M 34.0K sh | Sep 17, 2026 | Sep 18, 2026 traded Sep 17, 2026 | +1d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.28M 34.0K sh | Sep 15, 2026 | Sep 16, 2026 traded Sep 15, 2026 | +1d | SEC Form 4 | |
| 7 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $1.44M 15.0K sh | Sep 16, 2026 | Sep 16, 2026 traded Sep 16, 2026 | +0d | SEC Form 4 | |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $4.08M 41.0K sh | Sep 14, 2026 | Sep 14, 2026 traded Sep 14, 2026 | +0d | SEC Form 4 | |
| 14 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $4.36M 45.0K sh | Sep 11, 2026 | Sep 14, 2026 traded Sep 11, 2026 | +3d | SEC Form 4 | |
| 10 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $1.97M 20.5K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 10 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.67M 37.0K sh | Sep 8, 2026 | Sep 9, 2026 traded Sep 8, 2026 | +1d | SEC Form 4 | |
| 10 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.52M 36.0K sh | Sep 9, 2026 | Sep 9, 2026 traded Sep 9, 2026 | +0d | SEC Form 4 | |
| 24 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $4.63M 45.0K sh | Sep 3, 2026 | Sep 8, 2026 traded Sep 3, 2026 | +5d | SEC Form 4 | |
| 10 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.26M 31.5K sh | Sep 4, 2026 | Sep 8, 2026 traded Sep 4, 2026 | +4d | SEC Form 4 | |
| 5 | PSPoetting SierkChief Operating Officer | BNTXBioNTech SE Grant or award | A | — 10.1K sh | May 12, 2026 | May 13, 2026 traded May 12, 2026 | +1d | SEC Form 4 | |
| 9 | ZRZapata Gomez RamonChief Financial Officer | BNTXBioNTech SE Grant or award | A | — 18.9K sh | May 12, 2026 | May 13, 2026 traded May 12, 2026 | +1d | SEC Form 4 | |
| 9 | JKJimenez KylieChief People Officer | BNTXBioNTech SE Grant or award | A | — 10.5K sh | May 12, 2026 | May 13, 2026 traded May 12, 2026 | +1d | SEC Form 4 | |
| 5 | PSPoetting SierkChief Operating Officer | BNTXBioNTech SE Grant or award | A | — 12.6K sh | May 12, 2026 | May 13, 2026 traded May 12, 2026 | +1d | SEC Form 4 | |
| 9 | HAHanekamp AnnemarieChief Commercial Officer | BNTXBioNTech SE Grant or award | A | — 10.1K sh | May 12, 2026 | May 13, 2026 traded May 12, 2026 | +1d | SEC Form 4 | |
| 9 | RPRyan James Timothy PatrickSee remarks. | BNTXBioNTech SE Grant or award | A | — 10.1K sh | May 12, 2026 | May 13, 2026 traded May 12, 2026 | +1d | SEC Form 4 | |
| 9 | HAHanekamp AnnemarieChief Commercial Officer | BNTXBioNTech SE Grant or award | A | — 12.6K sh | May 12, 2026 | May 13, 2026 traded May 12, 2026 | +1d | SEC Form 4 | |
| 9 | JKJimenez KylieChief People Officer | BNTXBioNTech SE Grant or award | A | — 8,391 sh | May 12, 2026 | May 13, 2026 traded May 12, 2026 | +1d | SEC Form 4 | |
| 9 | RPRyan James Timothy PatrickSee remarks. | BNTXBioNTech SE Grant or award | A | — 12.6K sh | May 12, 2026 | May 13, 2026 traded May 12, 2026 | +1d | SEC Form 4 | |
| 9 | ZRZapata Gomez RamonChief Financial Officer | BNTXBioNTech SE Grant or award | A | — 15.1K sh | May 12, 2026 | May 13, 2026 traded May 12, 2026 | +1d | SEC Form 4 | |
| 18 | PSPoetting SierkChief Operating Officer | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $5.53M 50.0K sh | Apr 22, 2026 | Apr 23, 2026 traded Apr 22, 2026 | +1d | SEC Form 4 | |
See remarks. · May 13, 2026